Immunovant, Inc. (IMVT)
27.24
-0.15
(-0.55%)
USD |
NASDAQ |
Feb 25, 14:07
Immunovant Shareholders Equity (Annual) : 707.45M for March 31, 2025
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Boston Scientific Corp. | 24.23B |
| Viridian Therapeutics, Inc. | 671.64M |
| Plus Therapeutics, Inc. | -8.949M |
| Nutriband, Inc. | 6.429M |
| Definium Therapeutics, Inc. | 241.45M |